Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
作者信息
Sargin Gokhan, Yavaşoğlu Sare İlknur, Yavasoglu Irfan
机构信息
Department of Rheumatology, Aydın Adnan Menderes University School of Medicine, 09100 Efeler, Aydın, Turkey.
Aydın Adnan Menderes University, Faculty of Science and Letters, Department of Ecology, 09100 Efeler, Aydın, Turkey.
出版信息
Med Hypotheses. 2020 Jul;140:109756. doi: 10.1016/j.mehy.2020.109756. Epub 2020 Apr 22.
Abstract
摘要
相似文献
1
Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?在疟疾感染率较高的国家，2019冠状病毒病（COVID-19）的发病率是否较低？
Med Hypotheses. 2020 Jul;140:109756. doi: 10.1016/j.mehy.2020.109756. Epub 2020 Apr 22.
2
Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines.免疫调节作为 SARS-CoV-2 爆发期间的一种治疗选择：抗疟氨基喹啉的案例。
Front Immunol. 2020 Aug 28;11:2159. doi: 10.3389/fimmu.2020.02159. eCollection 2020.
3
Of chloroquine and COVID-19.关于氯喹和 COVID-19。
Antiviral Res. 2020 May;177:104762. doi: 10.1016/j.antiviral.2020.104762. Epub 2020 Mar 5.
4
Chloroquine and its derivatives in the management of COVID-19: A scoping review.氯喹及其衍生物在COVID-19治疗中的应用：一项范围综述。
Biomedica. 2020 Oct 30;40(Supl. 2):80-95. doi: 10.7705/biomedica.5478.
5
Chloroquine as a prophylactic agent against COVID-19?氯喹作为 COVID-19 的预防药物？
Int J Antimicrob Agents. 2020 Jun;55(6):105980. doi: 10.1016/j.ijantimicag.2020.105980. Epub 2020 Apr 12.
6
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.氯喹和羟氯喹在 2019 年冠状病毒病（COVID-19）中的应用。事实、虚构和炒作：批判性评价。
Int J Antimicrob Agents. 2020 Sep;56(3):106101. doi: 10.1016/j.ijantimicag.2020.106101. Epub 2020 Jul 17.
7
World War against COVID-19: How strong is our armamentarium?抗击新冠疫情之战：我们的武器库有多强大？
Med J Malaysia. 2020 May;75(3):314-315.
8
Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19.氯喹和羟氯喹用于治疗新型冠状病毒肺炎的安全性考量
Clin Microbiol Infect. 2020 Sep;26(9):1276-1277. doi: 10.1016/j.cmi.2020.05.006. Epub 2020 May 16.
9
Insights from nanomedicine into chloroquine efficacy against COVID-19.纳米医学对氯喹治疗 COVID-19 疗效的启示。
Nat Nanotechnol. 2020 Apr;15(4):247-249. doi: 10.1038/s41565-020-0674-9.
10
Chloroquine and hydroxychloroquine in covid-19.氯喹和羟氯喹在2019冠状病毒病中的应用
BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
引用本文的文献
1
The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: A review.血型与感染 SARS-CoV-2 风险或严重结局发展的关系：综述。
Rev Med Virol. 2022 Jan;32(1):e2247. doi: 10.1002/rmv.2247. Epub 2021 May 14.
2
The role of economic structural factors in determining pandemic mortality rates: Evidence from the COVID-19 outbreak in France.经济结构因素在决定大流行死亡率中的作用：来自法国新冠疫情爆发的证据。
Res Int Bus Finance. 2020 Dec;54:101281. doi: 10.1016/j.ribaf.2020.101281. Epub 2020 Jun 23.
3
COVID-19 pandemic: the implications of the natural history, challenges of diagnosis and management for care in sub-Saharan Africa.新冠疫情：撒哈拉以南非洲地区自然史的影响、诊断挑战及护理管理
Beni Suef Univ J Basic Appl Sci. 2021;10(1):16. doi: 10.1186/s43088-021-00106-x. Epub 2021 Mar 17.
4
Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of Infection Be Protective?撒哈拉以南非洲地区的 COVID-19 轻症病例较少：合并感染或近期感染史是否具有保护作用？
Front Immunol. 2021 Feb 18;12:565625. doi: 10.3389/fimmu.2021.565625. eCollection 2021.
5
SARS-CoV-2 and common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与常见免疫显性区域或许可以解释疟疾流行带中新冠病毒疾病（COVID-19）发病率较低的现象。
New Microbes New Infect. 2020 Nov;38:100817. doi: 10.1016/j.nmni.2020.100817. Epub 2020 Nov 19.
6
Individuals with a Rh-positive but not Rh-negative blood group are more vulnerable to SARS-CoV-2 infection: demographics and trend study on COVID-19 cases in Sudan.具有Rh阳性而非Rh阴性血型的个体更容易感染新冠病毒：苏丹新冠肺炎病例的人口统计学和趋势研究。
New Microbes New Infect. 2020 Nov;38:100763. doi: 10.1016/j.nmni.2020.100763. Epub 2020 Sep 22.
本文引用的文献
1
Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2.肾素-血管紧张素系统：新冠病毒揭示的人类免疫系统内部意外缺陷。
Med Hypotheses. 2020 Mar 21;140:109686. doi: 10.1016/j.mehy.2020.109686.
2
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.COVID-19：建议检查羟氯喹预防感染和进展的效果。
J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670. doi: 10.1093/jac/dkaa114.
3
Treatment of COVID-19: old tricks for new challenges.2019冠状病毒病的治疗：应对新挑战的老办法
Crit Care. 2020 Mar 16;24(1):91. doi: 10.1186/s13054-020-2818-6.
4
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?氯喹抗冠状病毒的抗病毒作用的新见解：对 COVID-19 有何期待？
Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.
5
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.羟氯喹和氯喹的作用机制：对风湿病学的影响。
Nat Rev Rheumatol. 2020 Mar;16(3):155-166. doi: 10.1038/s41584-020-0372-x. Epub 2020 Feb 7.
6
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.新型冠状病毒在武汉持续爆发中的进化及其刺突蛋白对人类传播风险的建模。
Sci China Life Sci. 2020 Mar;63(3):457-460. doi: 10.1007/s11427-020-1637-5. Epub 2020 Jan 21.
7
Cytokine release syndrome.细胞因子释放综合征。
J Immunother Cancer. 2018 Jun 15;6(1):56. doi: 10.1186/s40425-018-0343-9.
8
Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review.目前及未来在感染性、免疫性、肿瘤性和神经退行性疾病中应用氯喹和羟氯喹：小型综述。
Clin Drug Investig. 2018 Aug;38(8):653-671. doi: 10.1007/s40261-018-0656-y.
9
[Update on recommendations for screening for hydroxychloroquine retinopathy].[羟氯喹视网膜病变筛查建议的更新]
J Fr Ophtalmol. 2017 Nov;40(9):793-800. doi: 10.1016/j.jfo.2017.08.002. Epub 2017 Oct 18.
10
The path to eradication: a progress report on the malaria-eliminating countries.消除疟疾之路：消除疟疾国家的进展报告。
Lancet. 2016 Apr 23;387(10029):1775-84. doi: 10.1016/S0140-6736(16)00230-0.
Zotero 插件